What are Post-Marketing Surveillance and Pharmacovigilance?
Once a drug is approved and marketed, surveillance continues through pharmacovigilance. This involves collecting and analyzing data on adverse events reported by healthcare professionals and patients. It helps in identifying previously unrecognized side effects and in taking necessary actions like updating safety information, restricting use, or even withdrawing the drug from the market.
